DECREASED EFFECT OF INSULIN TO STIMULATE SKELETAL-MUSCLE BLOOD-FLOW IN OBESE MAN - A NOVEL MECHANISM FOR INSULIN RESISTANCE
DECREASED EFFECT OF INSULIN TO STIMULATE SKELETAL-MUSCLE BLOOD-FLOW IN OBESE MAN - A NOVEL MECHANISM FOR INSULIN RESISTANCE
复制标题
DOI:
10.1172/jci114644
复制
发表时间:
1990-06-01
影响因子:
15.9
通讯作者:
BARON, AD
中科院分区:
文献类型:
--
作者:
LAAKSO, M;EDELMAN, SV;BARON, AD
Obesity is characterized by decreased rates of skeletal muscle insulin-mediated glucose uptake (IMGU). Since IMGU equals the product of the arteriovenous glucose difference (AVGd) across muscle and blood flow into muscle, reduced blood flow and/or tissue activity (AVGd) can lead to decreased IMGU. To examine this issue, we studied six lean (weight 68 .+-. 3 kg, mean .+-. SEM) and six obese (94 .+-. 3 kg) men. The insulin dose-response curves for whole body and leg IMGU were constructed using the euglycemic clamp and leg balance techniques over a large range of serum insulin concentrations. In lean and obese subjects, whole body IMGU, AVGd, blood flow, and leg IMGU increased in a dose dependent fashion and maximal rates of all parameters were reduced in obese subjects compared to lean subjects. The dose-response curves for whole body IMGU, leg IMGU, and AVGd were right-shifted in obese subjects with an ED50 two- to threefold higher than that of lean subjects for each parameter. Leg blood flow increased approximately twofold from basal 2.7 .+-. 0.2 to 4.4 .+-. 0.2 dl/min in lean, P < 0.01, and from 2.5 .+-. 0.3 to 4.4 .+-. 0l.4 dl/min in obese subjects, P < 0.01. The ED50 for insulin''s effect to increase leg blood flow was about fourfold higher for obese (957 pmol/liter) than lean subjects (266 pmol/liter), P < 0.01. Therefore, decreased insulin sensitivity in human obesity is not only due to low glucose extraction in insulin-sensitive tissues but also to lower blood flow to these tissues. Thus, in vivo insulin resistance can be due to a defect in insulin action at the tissue level and/or a defect in insulin''s hemodynamic action to increase blood flow to insulin sensitive tissues.